Eli Lilly Receives FDA Breakthrough Therapy Designation for Alzheimer's Treatment

  ()
Eli Lilly and Co's shares traded 8% higher and reached a new 52-week high after the company reported the FDA granted its investigational antibody therapy donanemab Breakthrough Therapy designation for use in treating Alzheimer's disease. read more >

Analyst: Health Care Services/Tech Firm's 'Biggest Transaction Gets Even Bigger'

Research Report
  ()
How the acquisition has grown and its effects on CloudMD Software & Services are addressed in a Research Capital Corp. report. read more >

Price Target Raised on Biopharma Achieving Positive Atopic Dermatitis Study Results

Research Report
  ()
Aclaris Therapeutics' new clinical trial data and a recent financing are discussed in an H.C. Wainwright & Co. report. read more >

Biotech Reports Encouraging Efficacy Data in Wet AMD, Target Price Raised 66%

Research Report
  ()
These new results, from a Clearside Biomedical trial, are presented and interpreted in a ROTH Capital Partners report. read more >

3D Systems and CollPlant Biotech to Create Bioprinted Breast Reconstruction Treatment Solutions

  ()
3D Systems Corp. shares rose 27% after the company reported it is partnering with CollPlant Biotechnologies to develop bioprinted solutions use to improve breast reconstruction treatments. read more >

Anavex Posts Strong Correlated Biomarker Data in Phase 2 Adult Rett Syndrome Trial

  ()
Anavex Life Sciences shares traded 13% higher after the company reported that ANAVEX®2-73 (blarcamesine) biomarker correlated highly with the predetermined efficacy endpoints in its Phase 2 clinical trial of adult patients with Rett syndrome. read more >

Entera Bio Granted Patent for Oral Parathyroid Hormone by EU Patent Authority

  ()
Entera Bio shares traded 25% higher after the firm received a foundational patent from the EU patent office for its oral parathyroid hormone using its platform oral protein delivery technology to treat osteoporosis and hypoparathyroidism. read more >

Altimmune Posts Positive Interim Weight Loss Results in Phase 1 ALT-801 Trial

  ()
Altimmune Inc. shares traded 16% higher after the company reported positive interim data from a Phase 1 study of ALT-801 in overweight and obese trial participants. read more >

Biotech Reports Positive Preclinical COVID-19 Study Results

Research Report
  ()
These data and next steps for Novan's antiviral SB019 are provided in a ROTH Capital Partners report. read more >

Immuno-oncology Firm Advances Lead Asset in Mesothelioma

Research Report
  ()
The status of ONCOS-102 in several of Targovax's development programs is discussed in an H.C. Wainwright & Co. report. read more >

Clearside Biomed Shares Rise 37% on Positive Data in Phase 1/2a Wet AMD Trial

  ()
Clearside Biomedical shares reached a new 52-week high after the company reported that the first cohort in its dose-escalating Oasis Trial of CLS-AX for treatment of neovascular age-related macular degeneration met all primary endpoints. read more >

Enochian Bio's Shares Rise 54% After FDA Accepts Pre-IND Request for Potential HIV Cure

  ()
Shares of Enochian Biosciences Inc. traded higher after the company reported that the U.S. Food and Drug Administration accepted a pre-investigational new drug request for a potential functional cure or treatment for human immunodeficiency virus. read more >

Tilray Shares Climb Higher on Roll Out of New Medical Cannabis Brand Symbios

  ()
Tilray Inc. shares traded 11% higher after the company reported the launch of a new medical cannabis brand, Symbios, designed to provide medicinal users with a broader spectrum of formats and cannabinoid potencies at improved price points. read more >

Expert Investing Ideas

"Final results from AGN's Phase 2b COVID-19 trial are expected soon."

–André Uddin, Research Capital Corporation


"AGN is to continue a number of preclinical studies of DMT for stroke."

–André Uddin, Research Capital Corporation


"AGN [shares] are now in a vigorous uptrend."

–Clive Maund, CliveMaund.com


"VIV signed a partnership with CSA Animal Nutrition."

–Alex Koyfman, Penny Stock Millionaire


Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe
NASDAQ Biotech ARCA Pharmaceutical

Sorrento's COVID Test Approved in Mexico

Research Report
  ()
This and other recent developments involving Sorrento Therapeutics' pipeline and partners are covered in a Dawson James Securities report. read more >

Promising Psychedelic Drug Trials Show Potential for a New Biotech Boom

Contributed Research
  ()
McAlinden Research Partners notes that continued advances in psychedelic therapies show potential to drive an investment boom that could reshape the future of medicine and mental health therapies. read more >
News Update

Drug Repurposing Firm Launches Clinical Research Program in Pancreatic Cancer

News Update
  ()
Based on various positive preclinical and clinical studies, Algernon Pharmaceuticals is pursuing Ifenprodil as a potential treatment for pancreatic tumors. read more >